[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]
[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]
[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]
[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]
[Mindray Announces Second Quarter 2011 Financial Results Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million, anrease of 21.2% over]
[Bona Reports Second Quarter 2011 Financial Results Achieves non-GAAP net income(1) of US$1.6 million, meeting second quarter 2011 guidance Achieves gross margin of 46.9% in the second quarter of 2011 BEIJING, August 4, 2011 Bona Film Group Limited (Bona or the Company) (NASDAQ: BONA), a leading film distributor and vertically integrated film company in China, today announced its unaudited] [TABLE OF CONTENTS 2 BONA FILM GROUP LIMITED]
[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]
[Bona Reports Second Quarter 2011 Financial Results Achieves non-GAAP net income(1) of US$1.6 million, meeting second quarter 2011 guidance Achieves gross margin of 46.9% in the second quarter of 2011 BEIJING, August 4, 2011 Bona Film Group Limited (Bona or the Company) (NASDAQ: BONA), a leading film distributor and vertically integrated film company in China, today announced its unaudited] [TABLE OF CONTENTS 2 BONA FILM GROUP LIMITED]
[Sinovac Announces Management Changes -Chief Financial Officer Resigns - -Vice President of Sinovac Named Interim Chief Financial Officer BEIJING, August 5, 2011 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today the resignation of Jacob Chik Keung Ho, its Chief Financial Officer, for personal reasons. The Company has initiated an executive search for] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD. August 5]
[Sinovac Announces Management Changes -Chief Financial Officer Resigns - -Vice President of Sinovac Named Interim Chief Financial Officer BEIJING, August 5, 2011 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today the resignation of Jacob Chik Keung Ho, its Chief Financial Officer, for personal reasons. The Company has initiated an executive search for] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD. August 5]
